Gene therapy specific for ovarian cancer by IAI.3B promoter-driven oncolytic adenovirus

被引：0
|
作者：
Hamada, Katsuyuki [1 ]
机构：
[1] Ehime Univ, Matsuyama, Ehime, Japan
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3006
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Bioreducible polymer-conjugated hepatoma-specific oncolytic adenovirus for systemic cancer gene therapy
    Yun, Chae-Ok
    Kim, Pyung-Hwan
    Kim, Tae-il
    Yockman, James W.
    Kim, Sung Wan
    HUMAN GENE THERAPY, 2010, 21 (10) : 1405 - 1405
  • [42] Improved intravenous lentiviral gene therapy based on endothelial-specific promoter-driven factor VIII expression for hemophilia A
    Gong, Jie
    Yang, Rui
    Zhou, Min
    Chang, Lung-Ji
    MOLECULAR MEDICINE, 2023, 29 (01)
  • [43] Improved intravenous lentiviral gene therapy based on endothelial-specific promoter-driven factor VIII expression for hemophilia A
    Jie Gong
    Rui Yang
    Min Zhou
    Lung-Ji Chang
    Molecular Medicine, 29
  • [44] Transgenic studies with a keratin promoter-driven growth hormone transgene: Prospects for gene therapy
    Wang, XM
    Zinkel, S
    Polonsky, K
    Fuchs, E
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (01) : 219 - 226
  • [45] Transgenic studies with a keratin promoter-driven growth hormone transgene: Prospects for gene therapy
    Wang, X.
    Zinkel, S.
    Polonsky, K.
    Fuchs, E.
    Proceedings of the National Academy of Sciences of the United States of America, 94 (01):
  • [46] A safe, effective in vivo gene therapy for melanoma using tyrosinase promoter-driven cytosine deaminase gene
    Cao, GW
    Zhang, XQ
    He, X
    Chen, QL
    Qi, ZT
    IN VIVO, 1999, 13 (02): : 181 - 187
  • [47] Epididymis-specific promoter-driven gene targeting:: a new approach to control epididymal function?
    Suzuki, K
    Drevet, J
    Hinton, BT
    Huhtaniemi, I
    Lareyre, JJ
    Matusik, RJ
    Pons, E
    Poutanen, M
    Sipilä, P
    Orgebin-Crist, MC
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2004, 216 (1-2) : 15 - 22
  • [48] Comparison of long-term survival of cytomegalovirus promoter versus Rous Sarcoma virus promoter-driven thymidine kinase gene therapy in nude mice bearing human ovarian cancer
    Tong, XW
    Engehausen, DG
    Freund, CTF
    Agoulnik, I
    Oehler, MK
    Kim, TE
    Hasenburg, A
    Guo, ZS
    Contant, CF
    Woo, SLC
    Kieback, DG
    HYBRIDOMA, 1999, 18 (01): : 93 - 97
  • [49] Epididymis-specific promoter-driven gene targeting: A transcription factor which regulates epididymis-specific gene expression
    Suzuki, K
    Yu, XP
    Chaurand, P
    Araki, Y
    Lareyre, JJ
    Caprioli, RM
    Matusik, RJ
    Orgebin-Crist, MC
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2006, 250 (1-2) : 184 - 189
  • [50] Application of adenovirus-mediated human telomerase catalytic subunit (hTERT) gene promoter in ovarian cancer gene therapy
    Song, JS
    Yoon, WS
    Lee, KW
    Kim, MH
    Kim, KT
    Kim, H
    Kim, YT
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2003, 13 (04) : 517 - 521
12345